TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director May 22, 1998
TCL Archive Neutron Therapy “Treatment Of Choice” In Salivary Gland Tumors – 100 Percent Complete Reponses June 13, 1986
TCL Archive Greenwald Disagrees With WHT Report But Won’t Fight Decision; Will Ask For Limited Study, With Scope To Be Modified January 15, 1988
